133 related articles for article (PubMed ID: 11333738)
1. [Recommendations on the multidisciplinary management in patients with malignant glioma].
Graus F; Cerdá M; Piquer J; Reynés G; Santos M
Med Clin (Barc); 2001 Feb; 116(7):271-5. PubMed ID: 11333738
[No Abstract] [Full Text] [Related]
2. Cure of glioma: a space not yet occupied for the lesion.
Harrison JS; Kast WM
Cancer Invest; 2004; 22(3):479-80. PubMed ID: 15493370
[No Abstract] [Full Text] [Related]
3. Low-grade central nervous system tumors.
Lopes MB; Laws ER
Neurosurg Focus; 2002 Feb; 12(2):E1. PubMed ID: 16212318
[TBL] [Abstract][Full Text] [Related]
4. [Advances in molecular genetics and treatment of gliomas].
Hoang-Xuan K; Idbaih A
Bull Acad Natl Med; 2011 Jan; 195(1):11-20; discussion 20-1. PubMed ID: 22039700
[TBL] [Abstract][Full Text] [Related]
5. Diffusely infiltrative low-grade gliomas in adults.
Lang FF; Gilbert MR
J Clin Oncol; 2006 Mar; 24(8):1236-45. PubMed ID: 16525178
[TBL] [Abstract][Full Text] [Related]
6. An Update on Pediatric Gliomas.
Ahrendsen J; Alexandrescu S
Surg Pathol Clin; 2020 Jun; 13(2):217-233. PubMed ID: 32389263
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic strategies for local recurrent malignant glioma.
Sills AK; Duntsch C; Weimar J
Curr Treat Options Oncol; 2004 Dec; 5(6):491-7. PubMed ID: 15509482
[TBL] [Abstract][Full Text] [Related]
8. Clinical Utility of Positron Emission Tomography in Patients with Malignant Glioma.
Yano H; Shinoda J; Iwama T
Neurol Med Chir (Tokyo); 2017 Jul; 57(7):312-320. PubMed ID: 28458384
[TBL] [Abstract][Full Text] [Related]
9. [A practical guide for the management of gliomas].
Stupp R; Pica A; Mirimanoff RO; Michielin O
Bull Cancer; 2007 Sep; 94(9):817-22. PubMed ID: 17878102
[TBL] [Abstract][Full Text] [Related]
10. Current perspectives in gliomas.
Brock CS; Bower M
Med Oncol; 1997 Jun; 14(2):103-20. PubMed ID: 9330270
[TBL] [Abstract][Full Text] [Related]
11. Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
Braunstein S; Raleigh D; Bindra R; Mueller S; Haas-Kogan D
J Neurooncol; 2017 Sep; 134(3):541-549. PubMed ID: 28357536
[TBL] [Abstract][Full Text] [Related]
12. Patterns of care for adults with malignant glioma.
Shannon RP; Sayre JW; Sayre JJ
JAMA; 2005 May; 293(20):2469-70; author reply 2470. PubMed ID: 15914746
[No Abstract] [Full Text] [Related]
13. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
14. Malignant gliomas in 2005: where to GO from here?
Fisher PG; Buffler PA
JAMA; 2005 Feb; 293(5):615-7. PubMed ID: 15687318
[No Abstract] [Full Text] [Related]
15. Functional roles of enhancer of zeste homolog 2 in gliomas.
Yin Y; Qiu S; Peng Y
Gene; 2016 Jan; 576(1 Pt 2):189-94. PubMed ID: 26435191
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of 2-5A antisense against telomerase RNA and cisplatin for malignant gliomas.
Kondo Y; Komata T; Kondo S
Int J Oncol; 2001 Jun; 18(6):1287-92. PubMed ID: 11351264
[TBL] [Abstract][Full Text] [Related]
17. [The progress of comprehensive therapy of glioma].
Wang RZ; Gao J; Ma WB
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2305-6. PubMed ID: 19087686
[No Abstract] [Full Text] [Related]
18. Advances in the molecular genetics of gliomas - implications for classification and therapy.
Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic molecular markers in common adult gliomas.
Rivera AL; Pelloski CE
Expert Rev Mol Diagn; 2010 Jul; 10(5):637-49. PubMed ID: 20629512
[TBL] [Abstract][Full Text] [Related]
20. Genetics, prognosis and therapy of central nervous system tumors.
Watkins D; Rouleau GA
Cancer Detect Prev; 1994; 18(2):139-44. PubMed ID: 8025896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
